ヘッジホッグ経路阻害剤の世界市場:BCC、AML

LINEで送る

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• BCC – Market size and forecast 2018-2023
• AML – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 08: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 09: MARKET TRENDS
• Development of repurposed formulations
• Strategic alliances
• Funding for cancer-related research
PART 10: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 11: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• F. Hoffmann-La Roche Ltd.
• Inhibitor Therapeutics Inc.
• MAX BioPharma Inc.
• Mayne Pharma Group Ltd.
• PellePharm Inc.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
PART 12: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 13: EXPLORE TECHNAVIO


Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: BCC – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: BCC – Year-over-year growth 2019-2023 (%)
Exhibit 22: AML – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: AML – Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America – Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 49: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 50: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 51: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 52: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 53: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 54: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 55: Inhibitor Therapeutics Inc. – Vendor overview
Exhibit 56: Inhibitor Therapeutics Inc. – Organizational developments
Exhibit 57: Inhibitor Therapeutics Inc. – Key offerings
Exhibit 58: Inhibitor Therapeutics Inc. – Key customers
Exhibit 59: MAX BioPharma Inc. – Vendor overview
Exhibit 60: MAX BioPharma Inc. – Organizational developments
Exhibit 61: MAX BioPharma Inc. – Key offerings
Exhibit 62: MAX BioPharma Inc. – Key customers
Exhibit 63: Mayne Pharma Group Ltd. – Vendor overview
Exhibit 64: Mayne Pharma Group Ltd. – Business segments
Exhibit 65: Mayne Pharma Group Ltd. – Organizational developments
Exhibit 66: Mayne Pharma Group Ltd. – Geographic focus
Exhibit 67: Mayne Pharma Group Ltd. – Segment focus
Exhibit 68: Mayne Pharma Group Ltd. – Key offerings
Exhibit 69: Mayne Pharma Group Ltd. – Key customers
Exhibit 70: PellePharm Inc. – Vendor overview
Exhibit 71: PellePharm Inc. – Organizational developments
Exhibit 72: PellePharm Inc. – Key offerings
Exhibit 73: PellePharm Inc. – Key customers
Exhibit 74: Pfizer Inc. – Vendor overview
Exhibit 75: Pfizer Inc. – Business segments
Exhibit 76: Pfizer Inc. – Organizational developments
Exhibit 77: Pfizer Inc. – Geographic focus
Exhibit 78: Pfizer Inc. – Segment focus
Exhibit 79: Pfizer Inc. – Key offerings
Exhibit 80: Pfizer Inc. – Key customers
Exhibit 81: Sun Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 82: Sun Pharmaceutical Industries Ltd. – Product segments
Exhibit 83: Sun Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 84: Sun Pharmaceutical Industries Ltd. – Geographic focus
Exhibit 85: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibit 86: Sun Pharmaceutical Industries Ltd. – Key customers
Exhibit 87: Validation techniques employed for market sizing
Exhibit 88: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様